182 related articles for article (PubMed ID: 18355603)
21. Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant?
Junquera L; Gallego L
J Oral Maxillofac Surg; 2008 Jul; 66(7):1516-7. PubMed ID: 18571043
[No Abstract] [Full Text] [Related]
22. Osteonecrosis of jaws after bisphosphonates: an internet resource on the web for dentist.
Hon NC
Singapore Dent J; 2007 Dec; 29(1):19-21. PubMed ID: 18472526
[TBL] [Abstract][Full Text] [Related]
23. Sinus tracts--an early sign of bisphosphonate-associated osteonecrosis of the jaws?
Mawardi H; Treister N; Richardson P; Anderson K; Munshi N; Faiella RA; Woo SB
J Oral Maxillofac Surg; 2009 Mar; 67(3):593-601. PubMed ID: 19231786
[TBL] [Abstract][Full Text] [Related]
24. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
Grewal VS; Fayans EP
Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
[TBL] [Abstract][Full Text] [Related]
25. [Osteonecrosis of the jaw associated with the use of bisphosphonates in multiple myeloma: report of four cases and literature review].
Li LH; Wu XB; Chen WM; Chen JX; Wu Y; Chen SL
Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(42):2986-7. PubMed ID: 19080077
[TBL] [Abstract][Full Text] [Related]
26. Normal serum bone markers in bisphosphonate-induced osteonecrosis of the jaws.
Lehrer S; Montazem A; Ramanathan L; Pessin-Minsley M; Pfail J; Stock RG; Kogan R
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Sep; 106(3):389-91. PubMed ID: 18554944
[TBL] [Abstract][Full Text] [Related]
27. [Osteonecrosis of the jaw and bisphophonates in oncology].
Facon T; Bensadoun RJ; Blanc JL; Confavreux C; Gourmet R; Maes JM; Penel G; Vieillard MH; Woeller A
Bull Cancer; 2008 Apr; 95(4):413-8. PubMed ID: 18495570
[TBL] [Abstract][Full Text] [Related]
28. Treatment protocols of bisphosphonate-related osteonecrosis of the jaws.
Kyrgidis A; Koloutsos G; Vahtsevanos K
Head Neck; 2009 Aug; 31(8):1112-3; author reply 1113-4. PubMed ID: 19572289
[No Abstract] [Full Text] [Related]
29. Bisphosphonate osteonecrosis: a protocol for surgical management.
Markose G; Mackenzie FR; Currie WJ; Hislop WS
Br J Oral Maxillofac Surg; 2009 Jun; 47(4):294-7. PubMed ID: 19231046
[TBL] [Abstract][Full Text] [Related]
30. Bisphosphonates and osteonecrosis of the jaws.
Mariotti A
J Dent Educ; 2008 Aug; 72(8):919-29. PubMed ID: 18676801
[TBL] [Abstract][Full Text] [Related]
31. Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws.
Dodson TB
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):44-52. PubMed ID: 19371814
[TBL] [Abstract][Full Text] [Related]
32. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
Assael LA
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
[TBL] [Abstract][Full Text] [Related]
33. Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients.
Thumbigere-Math V; Sabino MC; Gopalakrishnan R; Huckabay S; Dudek AZ; Basu S; Hughes PJ; Michalowicz BS; Leach JW; Swenson KK; Swift JQ; Adkinson C; Basi DL
J Oral Maxillofac Surg; 2009 Sep; 67(9):1904-13. PubMed ID: 19686928
[TBL] [Abstract][Full Text] [Related]
34. Surgical approach with Er:YAG laser on osteonecrosis of the jaws (ONJ) in patients under bisphosphonate therapy (BPT).
Vescovi P; Manfredi M; Merigo E; Meleti M; Fornaini C; Rocca JP; Nammour S
Lasers Med Sci; 2010 Jan; 25(1):101-13. PubMed ID: 19543768
[TBL] [Abstract][Full Text] [Related]
35. Bisphosphonate-induced osteonecrosis of the jaw: long-term outcomes.
Katz J; George T; Sandow P; Machado M; Dickerson L; Moreb JS
J Support Oncol; 2009; 7(1):9-10. PubMed ID: 19278171
[No Abstract] [Full Text] [Related]
36. Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management.
Montebugnoli L; Felicetti L; Gissi DB; Pizzigallo A; Pelliccioni GA; Marchetti C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Oct; 104(4):473-7. PubMed ID: 17482847
[TBL] [Abstract][Full Text] [Related]
37. Management of patients on bisphosphonates and prevention of bisphosphonate-related osteonecrosis of the jaw.
Chu V; ;
Hawaii Dent J; 2008; 39(5):9-12; quiz 17. PubMed ID: 19189512
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of bisphosphonate-related osteonecrosis of the jaws: the utility of a national registry.
Gliklich R; Wilson J
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):71-4. PubMed ID: 19371817
[TBL] [Abstract][Full Text] [Related]
39. Dental management of patients with a history of bisphosphonate therapy: clinical dilemma.
Migliorati CA; Hsu CJ; Chopra S; Kaltman SS
J Calif Dent Assoc; 2008 Oct; 36(10):769-74. PubMed ID: 19044097
[TBL] [Abstract][Full Text] [Related]
40. American Association of Oral and Maxillofacial Surgeons position paper: Bisphosphonate-Related Osteonecrosis of the Jaws-2009 update: the need to refine the BRONJ definition.
Colella G; Campisi G; Fusco V
J Oral Maxillofac Surg; 2009 Dec; 67(12):2698-9. PubMed ID: 19925998
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
